ABECASSIS MICHAEL M received a stock award from PHARMACYTE BIOTECH, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/12/2025ACC: 0001683168-25-009112
Director
Since Aug 2021
+83.86K
Net shares
Net buyer
$17.2K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
100.73K acquired · 16.88K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+37.50K
Price / share
—
Trade value
—
% of position
2249.6%
12/12/2025
1.67K→39.17K
Common Stock
Direct
Shares
−16.88K
Price / share
$1.02
Trade value
$17.21K
% of position
43.1%
12/12/2025
39.17K→22.29K
Total
Net shares
+20.63K
Net value
-$17.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2025 | A · Award | +37.50K | — | — | 2249.6% | 1.67K | 39.17K |
| Common Stock Direct | 12/12/2025 | F · Tax Withholding | −16.88K | $1.02 | $17.21K | 43.1% | 39.17K | 22.29K |
| Total | +20.63K | -$17.21K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
63.23K shares
Shares
+63.23K
Strike price
1.22
Held after
63.23K
Exercisable
—
4/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock63.23K shares | 4/25/2025 | A · Award | +63.23K | 1.22 | — | 63.23K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned800.00
Total
800.00 indirect800.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 800.00 | Indirect |
| Total | 800.00 | 800.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported